Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Suppressor of cytokine signaling 4 (SOCS4) is an intracellular protein belonging to the SOCS family, functioning as a negative regulator of cytokine and growth factor signaling[1][2][4][5]. It contains a central SH2 domain and a C-terminal SOCS box that mediates its role in targeting signaling proteins for ubiquitination and proteasomal degradation[1][2][3]. SOCS4 is distinguished within its family by a long N-terminal domain, and although its exact physiological functions are still being elucidated, evidence indicates its involvement in tuning cytokine signaling in immune cells and potentially regulating signaling by receptor tyrosine kinases like EGFR[4]. Mouse models indicate that SOCS4 is important in anti-viral immune responses, particularly in T cell activation and the clearance of influenza virus through modulation of cytokine production, chemokine signaling, and CD8+ T cell trafficking; its absence can lead to increased susceptibility to infection and dysregulated inflammation[4]. There is limited information on direct roles in human disease, and it is not currently a druggable target.
For hypothetical drug targeting: Inhibition or enhancement of SOCS4 would modulate cytokine receptor signaling, primarily by blocking signaling through SH2-domain-mediated recruitment, increasing/decreasing protein ubiquitination and subsequent proteasomal degradation of signaling intermediates[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppressor of cytokine signaling 4 (SOCS4).